EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

TGF-β, EMT, and resistance to anti-cancer treatment

Xuecong Wang, Pieter Johan Adam Eichhorn, Jean Paul Thiery

Seminars in Cancer Biology · 2023-12 · 97 · 1-11

DOI: 10.1016/j.semcancer.2023.10.004 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Seminars in Cancer Biology, 2023-12. Verfasst von Xuecong Wang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Guangzhou National Laboratory, Guangzhou, China; Key Laboratory of Biological Targeting Diagnosis, Therapy and Rehabilitation of Guangdong Higher Edu…. Hauptthemen laut MEDLINE: Transforming Growth Factor beta, Carcinoma. Die Arbeit wurde bisher 177-mal zitiert (Crossref) und nennt 167 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Transforming growth factor-β (TGF-β) signaling regulates cell-specific programs involved in embryonic development, wound-healing, and immune homeostasis. Yet, during tumor progression, these TGF-β-mediated programs are altered, leading to epithelial cell plasticity and a reprogramming of epithelial cells into mesenchymal lineages through epithelial-to-mesenchymal transition (EMT), a critical developmental program in morphogenesis and organogenesis. These changes, in turn, lead to enhanced carcinoma cell invasion, metastasis, immune cell differentiation, immune evasion, and chemotherapy resistance. Here, we discuss EMT as one of the critical programs associated with carcinoma cell plasticity and the influence exerted by TGF-β on carcinoma status and function. We further explore the composition of carcinoma and other cell populations within the tumor microenvironment, and consider the relevant outcomes related to the programs associated with cancer treatment resistance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Transforming Growth Factor betaCarcinomaHumansEpithelial-Mesenchymal TransitionEpithelial CellsSignal TransductionCell Line, TumorTumor Microenvironment

Stichwörter der Autor:innen

Chemotherapy resistanceEMTImmune evasionPartial EMTTGF-β

Substanzen

Transforming Growth Factor beta

Autor:innen und Institutionen

  • Guangzhou National Laboratory, Guangzhou, China; Key Laboratory of Biological Targeting Diagnosis, Therapy and Rehabilitation of Guangdong Higher Education Institutes, The Fifth Affiliated Hospital of Guangzhou Medical…
  • Curtin Health Innovation Research Institute, Faculty of Health Sciences, Curtin University, GPO Box U1987, Perth, WA 6845, Australia; Curtin Medical School, Curtin University, GPO Box U1987, Perth, WA 6845, Australia; C…
  • Guangzhou National Laboratory, Guangzhou, China. Electronic address: tjp@gzlab.ac.cn.

Zitieren

APA

Wang, X., Eichhorn, P. J. A., & Thiery, J. P. (2023). TGF-β, EMT, and resistance to anti-cancer treatment. Seminars in Cancer Biology, 97, 1-11. https://doi.org/10.1016/j.semcancer.2023.10.004

Vancouver

Wang X, Eichhorn PJA, Thiery JP. TGF-β, EMT, and resistance to anti-cancer treatment. Seminars in Cancer Biology. 2023;97:1-11. doi:10.1016/j.semcancer.2023.10.004

BibTeX
@article{Wang2023,
  author = {Wang, Xuecong and Eichhorn, Pieter Johan Adam and Thiery, Jean Paul},
  title = {TGF-β, EMT, and resistance to anti-cancer treatment},
  journal = {Seminars in Cancer Biology},
  year = {2023},
  volume = {97},
  pages = {1--11},
  doi = {10.1016/j.semcancer.2023.10.004}
}
Kostenlos starten →